Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of ibuzatrelvir vs placebo in high-risk outpatients with COVID-19
jRCT2031240698Phase 3Recruiting
- Sponsor
- Pfizer
- Start
- Jun 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Ibuzatrelvir with Placebo (2 arms). Started Jun 2025; status: recruiting.
02
Drugs
ibuzatrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031240698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240698.